A Health Technology Assessment of the New Drugs for Inoperable or Metastatic Malignant Melanoma Patients [Internet].

In this health technology assessment we have compared the relative effectiveness and cost-effectiveness of seven new drugs used for the treatment of advanced malignant melanoma patients in the Norwegian setting. The drugs are: cobimetinib, dabrafenib, ipilimumab, nivolumab, pembrolizumab, trametinib and vemurafenib.

http://ift.tt/2qp4Rfr